z-logo
open-access-imgOpen Access
TDP‐43 Redistribution is an Early Event in Sporadic Amyotrophic Lateral Sclerosis
Author(s) -
Giordana Maria Teresa,
Piccinini Marco,
Grifoni Silvia,
De Marco Giovanni,
Vercellino Marco,
Magistrello Michela,
Pellerino Alessia,
Buccinnà Barbara,
Lupino Elisa,
Rinaudo Maria Teresa
Publication year - 2010
Publication title -
brain pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.986
H-Index - 132
eISSN - 1750-3639
pISSN - 1015-6305
DOI - 10.1111/j.1750-3639.2009.00284.x
Subject(s) - amyotrophic lateral sclerosis , motor neuron , ubiquitin , spinal cord , cytoplasmic inclusion , neuroscience , cytoplasm , immunostaining , biology , inclusion bodies , lower motor neuron , neurodegeneration , anterior horn cell , motor cortex , pathology , medicine , immunohistochemistry , microbiology and biotechnology , disease , gene , biochemistry , escherichia coli , stimulation
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder consisting of progressive loss of motor neurons. TDP‐43 has been identified as a component of ubiquitin‐immunoreactive inclusions of motor neurons in ALS. We focused on the diffuse cytoplasmic TDP‐43 immunoreactivity in ALS neurons, and quantitatively assessed it in comparison with skein/round TDP‐43 and ubiquitin immunostaining in motor neurons of 30 sporadic ALS cases. The percentage of spinal motor neurons with cytoplasmic TDP‐43 immunoreactivity was higher than that of ubiquitin‐immunoreactive ones. The percentage of TDP‐43‐positive motor neurons was independent of neuron counts in anterior horns, while the percentage of ubiquitinated neurons was inversely correlated. Aiming to define the cytosolic localization of TDP‐43, the immunoblot analysis of spinal cord and frontal cortex showed that full‐length TDP‐43, the 45 kDa form and ubiquitinated TDP‐43 are found in the soluble inclusion‐free fraction. The present data suggest that delocalization, accumulation and ubiquitination of TDP‐43 in the cytoplasm of motor neurons are early dysfunctions in the cascade of the events leading to motor neuron degeneration in ALS, preceding the formation of insoluble inclusion bodies. Being cytoplasmic accumulation an ongoing event during the course of the illness, a therapeutic approach to this incurable disease can be envisaged.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom